The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …
BMI’s commercial banking forecast series covers 62 countries accounting for 80% of global GDP. Each report, researched at source, features BMI’s independent assessment and 5-year forecasts to end-2017 for the commercial banking sector in each market. Using its expertise in both country risk and financial markets analysis, BMI has created exclusive models to forecast a wealth of key variables on the commercial banking sector. Historic and forecast data are provided for the sector’s total asset and liability growth, client loans, and client deposits. Forecasts for key ratios including the loan-deposit ratio and the loan-asset ratio are also included, as well as core macro-economic forecasts. Data is presented in both local currency and US dollar terms.
Each report examines key drivers of growth and future prospects, including the macroeconomic situation, the level of development and potential for growth of the banking sector, the commercial initiatives of major players, government policy and the regulatory environment.
Central to BMI’s analysis are our unique Commercial Banking Business Environment Ratings. BMI’s unique country-comparative Risk-Reward Rating provides a clear, quantified, independent assessment of the opportunities and dangers of operating in each market. The methodology draws together our in-depth knowledge of competitive pressures, our comprehensive industry market forecasts, and our Country Risk team’s unrivalled analysis of economic, political and operational risks.
The reports also feature profiles of leading banks, covering total assets, liabilities, client deposits, lending, bond holdings, main products and services, competitive positioning and ownership structure.